[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 58,333
Sort by:

2019 Pressure Ulcers Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Pressure Ulcers Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pressure Ulcers. It presents in-depth analysis of Pressure Ulcers clinical trials across markets and companies ...

April 2019 78 pages

2019 Primary Biliary Cirrhosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Primary Biliary Cirrhosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Primary Biliary Cirrhosis. It presents in-depth analysis of Primary Biliary Cirrhosis clinical trials ...

April 2019 95 pages

2019 Primary Dysmenorrhea Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Primary Dysmenorrhea Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Primary Dysmenorrhea. It presents in-depth analysis of Primary Dysmenorrhea clinical trials across markets and companies ...

April 2019 58 pages

2019 Primary Hyperparathyroidism Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Primary Hyperparathyroidism Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Primary Hyperparathyroidism. It presents in-depth analysis of Primary Hyperparathyroidism clinical trials across markets and companies ...

April 2019 64 pages

2019 Primary Immune Deficiency (PID) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Primary Immune Deficiency (PID) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Primary Immune Deficiency (PID). It presents in-depth analysis of Primary Immune Deficiency (PID) clinical trials ...

April 2019 112 pages

2019 Primary Progressive Multiple Sclerosis (PPMS) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... - “2019 Primary Progressive Multiple Sclerosis (PPMS) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Primary Progressive Multiple Sclerosis (PPMS). It presents in-depth analysis of Primary Progressive Multiple Sclerosis (PPMS ...

April 2019 65 pages

2019 Primary Sclerosing Cholangitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Primary Sclerosing Cholangitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Primary Sclerosing Cholangitis. It presents in-depth analysis of Primary Sclerosing Cholangitis clinical trials ...

April 2019 80 pages

2019 Primary Systemic Amyloidosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Primary Systemic Amyloidosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Primary Systemic Amyloidosis. It presents in-depth analysis of Primary Systemic Amyloidosis clinical trials ...

April 2019 98 pages

2019 Proctitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Proctitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Proctitis. It presents in-depth analysis of Proctitis clinical trials across markets and companies ...

April 2019 42 pages

2019 Progressive Supranuclear Palsy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Progressive Supranuclear Palsy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Progressive Supranuclear Palsy. It presents in-depth analysis of Progressive Supranuclear Palsy clinical trials ...

April 2019 66 pages

2019 Proliferative Diabetic Retinopathy (PDR) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Proliferative Diabetic Retinopathy (PDR) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Proliferative Diabetic Retinopathy (PDR). It presents in-depth analysis of Proliferative Diabetic Retinopathy (PDR) clinical trials ...

April 2019 94 pages

2019 Proliferative Vitreoretinopathy (PVR) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Proliferative Vitreoretinopathy (PVR) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Proliferative Vitreoretinopathy (PVR). It presents in-depth analysis of Proliferative Vitreoretinopathy (PVR) clinical trials ...

April 2019 42 pages

2019 Prostatic Intraepithelial Neoplasia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Prostatic Intraepithelial Neoplasia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Prostatic Intraepithelial Neoplasia. It presents in-depth analysis of Prostatic Intraepithelial Neoplasia clinical trials ...

April 2019 35 pages

2019 Prosthesis-Related Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Prosthesis-Related Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Prosthesis-Related Infections. It presents in-depth analysis of Prosthesis-Related Infections clinical trials across markets and companies ...

April 2019 42 pages

2019 Prosthetic joint infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Prosthetic joint infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Prosthetic joint infections. It presents in-depth analysis of Prosthetic joint infections clinical trials ...

April 2019 58 pages

2019 Proteinuria Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Proteinuria Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Proteinuria. It presents in-depth analysis of Proteinuria clinical trials across markets and companies ...

April 2019 228 pages

2019 Prurigo Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Prurigo Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Prurigo. It presents in-depth analysis of Prurigo clinical trials across markets and companies ...

April 2019 48 pages

2019 Pruritus Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Pruritus Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pruritus. It presents in-depth analysis of Pruritus clinical trials across markets and companies ...

April 2019 276 pages

2019 Pseudoexfoliation Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Pseudoexfoliation Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pseudoexfoliation Syndrome. It presents in-depth analysis of Pseudoexfoliation Syndrome clinical trials across markets and companies ...

April 2019 41 pages

2019 Pseudomonas aeruginosa Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Pseudomonas aeruginosa Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pseudomonas aeruginosa Infections. It presents in-depth analysis of Pseudomonas aeruginosa Infections clinical trials ...

April 2019 80 pages

2019 Pseudomonas Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Pseudomonas Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pseudomonas Infections. It presents in-depth analysis of Pseudomonas Infections clinical trials across markets and companies ...

April 2019 109 pages

2019 Psoriatic Arthritis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Psoriatic Arthritis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Psoriatic Arthritis. It presents in-depth analysis of Psoriatic Arthritis clinical trials across markets and companies ...

April 2019 228 pages

2019 Psychotic Major Depression Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Psychotic Major Depression Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Psychotic Major Depression. It presents in-depth analysis of Psychotic Major Depression clinical trials ...

April 2019 46 pages

2019 Pterygium Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Pterygium Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pterygium. It presents in-depth analysis of Pterygium clinical trials across markets and companies ...

April 2019 58 pages

2019 Pulmonary Arterial Hypertension Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Pulmonary Arterial Hypertension Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pulmonary Arterial Hypertension. It presents in-depth analysis of Pulmonary Arterial Hypertension clinical trials ...

April 2019 493 pages

2019 Pulmonary Edema Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Pulmonary Edema Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pulmonary Edema. It presents in-depth analysis of Pulmonary Edema clinical trials across markets and companies ...

April 2019 49 pages

2019 Pulmonary Embolism Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Pulmonary Embolism Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pulmonary Embolism. It presents in-depth analysis of Pulmonary Embolism clinical trials across markets and companies ...

April 2019 181 pages

2019 Pulmonary Fibrosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Pulmonary Fibrosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pulmonary Fibrosis. It presents in-depth analysis of Pulmonary Fibrosis clinical trials across markets and companies ...

April 2019 291 pages

2019 Pulmonary Inflammation Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Pulmonary Inflammation Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pulmonary Inflammation. It presents in-depth analysis of Pulmonary Inflammation clinical trials across markets and companies ...

April 2019 54 pages

2019 Pulmonary Tuberculosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Pulmonary Tuberculosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pulmonary Tuberculosis. It presents in-depth analysis of Pulmonary Tuberculosis clinical trials across markets and companies ...

April 2019 157 pages

2019 Pyelonephritis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Pyelonephritis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pyelonephritis. It presents in-depth analysis of Pyelonephritis clinical trials across markets and companies ...

April 2019 79 pages

2019 Rabies Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Rabies Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Rabies. It presents in-depth analysis of Rabies clinical trials across markets and companies ...

April 2019 95 pages

2019 Radiation Induced Nausea and Vomiting (RINV) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Radiation Induced Nausea and Vomiting (RINV) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Radiation Induced Nausea and Vomiting ...

April 2019 41 pages

2019 Radiculopathy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Radiculopathy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Radiculopathy. It presents in-depth analysis of Radiculopathy clinical trials across markets and companies ...

April 2019 111 pages

2019 Radiodermatitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Radiodermatitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Radiodermatitis. It presents in-depth analysis of Radiodermatitis clinical trials across markets and companies ...

April 2019 69 pages

2019 Ragweed Pollen Allergy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Ragweed Pollen Allergy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Ragweed Pollen Allergy. It presents in-depth analysis of Ragweed Pollen Allergy clinical trials ...

April 2019 37 pages

2019 Raynauds Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Raynauds Disease Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Raynauds Disease. It presents in-depth analysis of Raynauds Disease clinical trials across markets and companies ...

April 2019 64 pages

2019 Recurrent Abortion Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Recurrent Abortion Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Recurrent Abortion. It presents in-depth analysis of Recurrent Abortion clinical trials across markets and companies ...

April 2019 70 pages

2019 Recurrent Glioblastoma Multiforme (GBM) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Recurrent Glioblastoma Multiforme (GBM) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Recurrent Glioblastoma Multiforme (GBM). It presents in-depth analysis of Recurrent Glioblastoma Multiforme (GBM) clinical trials ...

April 2019 327 pages

2019 Recurrent Head And Neck Cancer Squamous Cell Carcinoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... - “2019 Recurrent Head And Neck Cancer Squamous Cell Carcinoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Recurrent Head And Neck ...

April 2019 220 pages

2019 Recurrent Malignant Glioma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Recurrent Malignant Glioma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Recurrent Malignant Glioma. It presents in-depth analysis of Recurrent Malignant Glioma clinical trials ...

April 2019 170 pages

2019 Recurrent Medulloblastoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Recurrent Medulloblastoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Recurrent Medulloblastoma. It presents in-depth analysis of Recurrent Medulloblastoma clinical trials across markets and companies ...

April 2019 67 pages

2019 Refractory Acute Myeloid Leukemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Refractory Acute Myeloid Leukemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Refractory Acute Myeloid Leukemia. It presents in-depth analysis of Refractory Acute Myeloid Leukemia clinical trials ...

April 2019 414 pages

2019 Refractory Anemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Refractory Anemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Refractory Anemia. It presents in-depth analysis of Refractory Anemia clinical trials across markets and companies ...

April 2019 70 pages

2019 Refractory Anemia With Excess Blasts Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... - “2019 Refractory Anemia With Excess Blasts Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Refractory Anemia With Excess Blasts. It presents in-depth analysis of Refractory Anemia With Excess Blasts ...

April 2019 62 pages

2019 Refractory Anemia With Ringed Sideroblasts Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... - “2019 Refractory Anemia With Ringed Sideroblasts Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Refractory Anemia With Ringed Sideroblasts. It presents in-depth analysis of Refractory Anemia With Ringed Sideroblasts ...

April 2019 39 pages

2019 Refractory Angina Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Refractory Angina Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Refractory Angina. It presents in-depth analysis of Refractory Angina clinical trials across markets and companies ...

April 2019 38 pages

2019 Refractory Chronic Lymphocytic Leukemia (CLL) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... - “2019 Refractory Chronic Lymphocytic Leukemia (CLL) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Refractory Chronic Lymphocytic Leukemia (CLL). It presents in-depth analysis of Refractory Chronic Lymphocytic Leukemia (CLL ...

April 2019 280 pages

2019 Regurgitation Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Regurgitation Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Regurgitation. It presents in-depth analysis of Regurgitation clinical trials across markets and companies ...

April 2019 65 pages

2019 Relapsed Acute Myeloid Leukemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Relapsed Acute Myeloid Leukemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Relapsed Acute Myeloid Leukemia. It presents in-depth analysis of Relapsed Acute Myeloid Leukemia clinical trials ...

April 2019 417 pages

Filters

Search

Categories

60
12,968
1,223
4,429
2
1
10,890
2,818
15,138
67
8,921
1
1,229
586

Publishers

58,333

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
58,296

Price

Date

Pages

Offers